Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.44 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexanone SCHEMBL6517734 | 0.96 | LMNA (0.52) | LMNATRIM24TRIM33ALDH1A1BCHE | |
| Ethylene SCHEMBL140298 | 0.90 | LMNA (0.55) | LMNABCHEACHEPTGS2 | |
| Cyclohexanone SCHEMBL16666829 | 0.89 | LMNA (0.44) | LMNATRIM24TRIM33ALDH1A1BCHE | |
| SCHEMBL2698061 | 0.87 | LMNA (0.63) | LMNATRIM24TRIM33ALDH1A1BCHE | |
| Ethylene SCHEMBL10339595 | 0.87 | LMNA (0.36) | LMNATRIM24TRIM33ALDH1A1 | |
| Ethylene SCHEMBL2909659 | 0.86 | LMNA (0.50) | LMNABCHEACHEPTGS2 | |
| Cyclohexanone SCHEMBL16666225 | 0.85 | LMNA (0.41) | LMNATRIM24TRIM33ALDH1A1BCHE | |
| Cyclopentanone SCHEMBL16667061 | 0.83 | LMNA (0.43) | LMNATRIM24TRIM33ALDH1A1BCHE | |
| Ethylene SCHEMBL4424062 | 0.82 | LMNA (0.50) | LMNABCHEACHEPTGS2 | |
| Ethylene SCHEMBL9049781 | 0.81 | LMNA (0.44) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57048930-A | — | — | None | — | — | JP | disclosed |
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
| JP-S5748930-A | PREPARATION OF ACETAL | SAKURAI HIDEKI | 1982-03-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | AADAT, CBS, CTH | LMNA 4238/4885TRIM24 3648/4885TRIM33 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.